This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Assistance Publique-Hopitaux De Paris, Institut National De La Santé Et De La Recherche Médicale (Inserm), Sorbonne Université. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 331 
1 out of 22 
1 out of 266 Years Active: 2026
Title: Jérémie Gautheron: Inventor in Liver Disease Research
Introduction
Jérémie Gautheron is an inventor associated with Alfortville, France. His patent work concerns compounds intended to prevent or treat non-alcoholic fatty liver disease (NAFLD).
Latest Patents
Gautheron is associated with 1 patent: “Compounds for Use (in Particular RIPA-56) in the Prevention and/or Treatment of Non-Alcoholic Fatty Liver Disease.” The invention describes compounds and compositions for preventing or treating NAFLD, including hepatic steatosis and non-alcoholic steatohepatitis (NASH).
Career Highlights
Gautheron’s listed institutional affiliations include Sorbonne Université and the French National Institute of Health and Medical Research (Inserm).
Collaborations
His listed coworker is Vlad Ratziu. Their shared research context is reflected in the patent’s focus on potential therapeutic approaches to NAFLD.
Conclusion
Jérémie Gautheron’s patent activity connects his research affiliations with the development of compounds aimed at addressing NAFLD and related liver conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile